RANDI HATTON: Open Payments
NPI 1578153391 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$646 in 35 payments from 21 companies in 2025. Trend: 2023 $237 · 2024 $1,017 · 2025 $646
Food & beverage: $646
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $80 |
| Astellas Pharma US Inc | 4 | $73 |
| Sumitomo Pharma America, Inc. | 4 | $62 |
| Corium, LLC | 3 | $60 |
| Tris Pharma Inc | 2 | $43 |
| Becton, Dickinson and Company | 1 | $36 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Lilly USA, LLC | 2 | $34 |
| Exeltis, USA Inc. | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
Products named: Veozah, MYFEMBREE, Azstarys, Dyanavel XR, VRAYLAR, HemoSphere, JARDIANCE, REXULTI.
Industry payments across AL — which companies pay providers there.
